Point72 Asset Management
IART icon

Point72 Asset Management’s Integra LifeSciences IART Stock Holding History

Point72 Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50,000
Closed -$2.79M – 1422
2019
Q1 		$2.79M Buy
+50,000
New +$2.55M 0.01% 663
2017
Q1 		– Sell
-200,000
Closed -$8.58M – 870
2016
Q4 		$8.58M Hold
200,000
– – 0.06% 343
2016
Q3 		$8.26M Buy
+200,000
New +$8.38M 0.06% 316

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Point72 Asset Management's IART Position: Q2 2024 in Review

Point72 Asset Management sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 254,862 shares — an estimated $9.03M sold.

Point72 Asset Management first reported a position in IART in Q3 2015 and held it in 14 quarters. The position peaked at $47.7M in Q3 2019. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Point72 Asset Management reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Point72 Asset Management sold 254,862 Integra LifeSciences shares in Q2 2024, an estimated $9.03M.
  • Point72 Asset Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 14 quarters.
  • Point72 Asset Management's Integra LifeSciences position peaked at $47.7M in Q3 2019.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.